Study to Evaluate Preventive Effect of Ayurveda and Homeopathy Treatment in COVID 19

Phase 3

Completed

Conditions: Healthy Human Volunteers who have high chances of exposure to COVID 19 patients

Registration Number: CTRI/2020/04/024731

Lead Sponsor: Superintendent

Brief Summary: The COVID 19 outbreak has been declared as pandemic by the world health organisation. In view of lack of precise treatment or vaccine, the incidence and mortality due to the infection remain high and are very high. Ayurveda explains many medications and treatments in the management of febrile illnesses (Jwara) and diseases of respiratory system (Pranavaha Srotsa) which are being practised since many years and are proven effective. Hence it is high time to evaluate its effect as a preventive measure in symptoms of respiratory system infection seen in COVID 19 patients. Ayurveda explains many medications andtreatments in the management of febrile illnesses (Jwara) and diseases ofrespiratory system (PranavahaSrotsa) which are being practised since many yearsand are proven effective. Hence it is high time to evaluate its effect as apreventive measure in symptoms of respiratory system infection seen in COVID 19patients. Rasayana is the Rejuvenation branch of Ayurvedic medicine. Rasayanatreatments were traditionally utilized after a period where the body waswarn-down or depleted. Rasayana therapies are also used to remedy old age,before the term â€˜anti-ageingâ€™, there was Rasayana. Many classical formulationsmentioned in Ayurvedic classic are excellent Rasayana medicines which can beused in treatment of various diseases including Jwara, Kasa, Kshaya.SamshamaniVati, KhadiradiVati, Dashmoola katutrayadi GhanVati are suchmedicines which can be useful in this condition. Nasya with AnuTaila inPratimarshaMatra (2 drops) is a remedy mentioned in Dinacharya that has shownbeneficial effects in many URTI conditions. Arsenic album 30 a homeopathicmedicine that is claimed to be beneficial in prevention from COVID 19infection.

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 50

Inclusion Criteria

Subjects who are not suffering from active illness due to infecction at the time of inclusion.

Exclusion Criteria

1.Subjects suffering from active illness due to infection at the time of inclusion.
2.Subjects suffering from uncontrolled DM, HTN etc.
Subjects who are known cases of immune-compromised or autoimmune condition such as HIV.
4.Pregnant and lactating women.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Episodes and severity of symptoms of respiratory tract infection (cold, sore throat, dry cough, breathlessness) in subjects who may get direct or indirect exposure to COVID 19 during lockdown in March and April 2020	From Baseline till the end of 15 days

Secondary Outcome Measures

Name	Time	Method
Incidence of COVID 19 infection in study population	From Baseline till the end of 15 days
Requirement of treatment for symptoms developed, if any, during study period	From Baseline till the end of 15 days
Analysis of adverse events, if any	From Baseline till the end of 15 days

Trial Locations

Locations (1): Parul Ayurved Hospital
🇮🇳
Vadodara, GUJARAT, India
Parul Ayurved Hospital
🇮🇳Vadodara, GUJARAT, India
Dr Hemant Toshikhane
Principal investigator
8469496525
drhemantt@gmail.com